No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it offers Amblyopia recovery services; and sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.
www.chaojueye.comNo one on the platform currently holds 2219.HK.
No tracked institution reports a position in 2219.HK as of their last filing.
No one on the platform has traded 2219.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.0% | 11.4% | — | — | — | |
| Rev. Growth % | -3.2% | 11.4% | ||||
| Profit Margin % | 13.5% | 15.9% | ||||
| Free Cash Flow Margin % | 8.3% | 17.7% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.5B | +13.4% | $0.26 | $0.26–$0.26 | — | 1 |
| 2027 | $1.7B | +9.5% | $0.28 | $0.28–$0.28 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2219.HKChaoju Eye Care Holdings Limited | $2.44 | -1.42% | $1.7B | — |
| 0314.HKSipai Health Technology Co., Ltd. | $1.65 | +3.13% | $1.2B | — |
| 1526.HKRici Healthcare Holdings Limited | $0.81 | -4.71% | $1.3B | — |
| 1846.HKEuroEyes International Eye Clinic Limited | $2.30 | +0.00% | $735M | — |
| 2348.HKDawnrays Pharmaceutical (Holdings) Limited | $0.98 | +0.51% | $1.5B | — |
| 2407.HKGaush Meditech Ltd | $4.74 | +1.94% |
Source: Financial Modeling Prep · peers by sector/industry
| $701M |
| — |
| 2453.HKConcord Healthcare Grp Co Ltd | $0.73 | +2.82% | $572M | — |